We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Up Front | Feb 2013

Chief Medical Editor’s Page

As this is my first editorial in 2013, I would like to wish you all a very healthy, happy, and prosperous year.

I am privileged to introduce the February 2013 issue, which highlights one of my favorite topics: cataract surgery. In this month’s Annual Cataract Complications issue, some of the world’s top experts in cataract surgery rely on their extensive experience to entertain a variety of key subjects. First, Alessandro Franchini, MD; Rupert Menapace, MD, FEBO; and Pierre-Jean Pisella, MD, PhD, share strategies for the correction of IOL power surprises. Amar Agarwal, MS, FRCS, FRCOphth, one of the gurus of complicated cataract surgery, and his team in India tackle the issue of posterior capsular rupture. Then we head down to the southwest coast of India with Arup Chakrabarti, MS, who provides a thorough overview of phaco techniques for rock-hard nuclei—a challenge to us all.

Also covered in this issue is IOL explantation—a surgical necessity that is fortunately rare in our day but should be a part of every cataract surgeon’s armamentarium. This subject is discussed with case reports from Charles Claoué, MA(Cantab), MD, DO, FRCS, FRCOphth, FEBO, MAE; Brian C. Little, MA, FRCS, FRCOphth; Daniela M.V. Marques, MD, PhD; Frederico F. Marques, MD, PhD; and Abhay R. Vasavada, MBBS, MS, FRCS. Last, on the road to better prophylaxis, Anders Behndig, MD, PhD, describes the use of the only CE-approved pharmaceutical intracameral cefuroxime formulation, which was the agent used by the European Society of Cataract & Refractive Surgeons (ESCRS) many years ago in its study on cefuroxime as primary prophylaxis in clear corneal cataract surgery.

We will all agree that cataract surgery is and will probably remain the safest and most effective surgical procedure performed in humans globally. This issue of CRST Europe raises the bar by sharing experts’ knowledge about how to approach complications that often can result in less than optimal outcomes. I hope you find this issue informative, and I, like you, look forward to having it on my office desk as a valuable guide on the latest techniques from experts all around the world.